William E. Rote, Chief Research Officer: Travere Therapeutics TVTX Sell · Filed 04/23

Trade details

Type: Insider sale
Amount: $355,719
Shares · price: 9,100 sh · $39.09 a share
Held after: 113,987 sh
Stock: Travere Therapeutics TVTX
Person: William E. RoteChief Research Officer
Trade date: 26/04/22
Filed: 26/04/23
Days to filing: 1 days

Sold 7.4% of holdings

Share of holding sold: 7.4%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 03/23~05/22

William E. Rote's recent trades

William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$7.1M
112,850 sh
$7.1M
Filed 09/16
Traded 09/16
William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.3M
96,198 sh
$6.3M
Filed 09/15
Traded 09/15
William E. RoteChief Research Officer
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$121.4K
2,763 sh
$121.4K
Filed 05/06
Traded 05/06
William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$121.4K
2,763 sh
$121.4K
Filed 05/06
Traded 05/06
William E. RoteChief Research Officer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$355.7K
9,100 sh
$355.7K
Filed 04/22
Traded 04/22

William E. Rote, Chief Officer — sold $355.7K of Travere Therapeutics TVTX · 7.4% of holdings · 10b5-1 plan | Whalegun